In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...
This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...
Asia has lagged the West on GLP‑1 weight‑loss drugs, but rising obesity, cheaper generics and supportive health systems in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results